Patient P-03200
Therapy response
Stable
Tolerance
Deteriorating
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
36%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 ONX-7 started — Baseline state S16
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- Nutritional resilience-10
- Toxicity+9
- Inflammatory activity+8
- Treatment adherence-8
- GI instability+7
What helped?
No interventions yet.
LIFE OS recommendation
Dosing / Timing Recommendation DT-01
59%
probability of meaningful tolerance improvement
- 284 similar trajectories
- 85% showed improvement
- median effect visible after 5 days
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Energy level
Daily log5.1/10
improving · +0.3 vs previous 14 d
Stress level
Daily log5.2/10
stable · -0.2 vs previous 14 d
Pessimism score
Daily log4.3/10
improving · -0.5 vs previous 14 d
Sleep quality
Wearable44.9/100
improving · +3.6 vs previous 14 d
Libido
Daily log3.6/10
stable · +0.1 vs previous 14 d
HRV
Wearable25.4 ms
stable · -0.1 vs previous 14 d
Toxicity
Blood25.1/100
improving · -1.2 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 56 from the failing basin, 31 from restoration.
Would help
- DT-01 Dosing / Timing Recommendation85% improved among 13 similar · onset 5 d · confidence 55%
- HY-01 Hydration Protocol67% improved among 9 similar · onset 4 d · confidence 55%
- NP-02 Dietary Support Protocol56% improved among 9 similar · onset 10 d · confidence 55%
- More proteinGI -6.8 next day on high-intake days · n 20
Would not help
- AD-05 Adherence Supportonly 30% improved among 10 similar
- Keep alcohol lowGI +4.8 next day on high-intake days · n 27
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-6.8supporter · 95%
- Alcohol+4.8detractor · 95%
- Histamine load+2.6no signal · 42%
- Dietary fat load-1.6no signal · 24%
- Caffeine-1.2no signal · 21%
- Lactose+0.9no signal · 16%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Butyrate / short-chain fatty acid production ↓45
- MicrobiomeF. prausnitzii depleted
- Daily logFibre intake low in recent food logs
- Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer
- Autonomic recovery ↓20
- Wearable3,791 steps/day
- Inflammatory signalling ↑15
- WearableHRV 25 ms, trending down
DNA
Fictional pharmacogenomic panel
- CYP2D6 Normal metabolizerExpected exposure
Microbiome
Shannon diversity 4.5 · butyrate capacity 48/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiLow
- Bacteroides fragilisNormal
- Bifidobacterium longumLow
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 29 ms
- Sleep
- 7.6 h
- Steps
- 4,034
- Resting HR
- 58 bpm
Daily log: GI score 39, nutritional resilience 47, adherence 87.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- A 15-minute walk after lunch
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: oral nutrition supplement with lunch
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.